| Neutralization escape by SARS-CoV-2 Omicron subvariants BA. 2.12. 1, BA. 4, and BA. 5 NP Hachmann, J Miller, AY Collier, JD Ventura, J Yu, M Rowe, ... New England Journal of Medicine 387 (1), 86-88, 2022 | 591 | 2022 |
| Neutralization of the SARS-CoV-2 Omicron BA. 1 and BA. 2 variants J Yu, AY Collier, M Rowe, F Mardas, JD Ventura, H Wan, J Miller, ... New England Journal of Medicine 386 (16), 1579-1580, 2022 | 332 | 2022 |
| Differential kinetics of immune responses elicited by Covid-19 vaccines AY Collier, J Yu, K McMahan, J Liu, A Chandrashekar, JS Maron, C Atyeo, ... New England Journal of Medicine 385 (21), 2010-2012, 2021 | 260 | 2021 |
| Immunogenicity of BA. 5 bivalent mRNA vaccine boosters AY Collier, J Miller, NP Hachmann, K McMahan, J Liu, EA Bondzie, ... New England Journal of Medicine 388 (6), 565-567, 2023 | 192 | 2023 |
| The NK cell receptor NKp46 recognizes ecto-calreticulin on ER-stressed cells S Sen Santara, DJ Lee, Â Crespo, JJ Hu, C Walker, X Ma, Y Zhang, ... Nature 616 (7956), 348-356, 2023 | 85 | 2023 |
| Neutralization escape by SARS-CoV-2 Omicron subvariant BA. 2.86 N Lasrado, YC Ai-ris, NP Hachmann, J Miller, M Rowe, ED Schonberg, ... Vaccine 41 (47), 6904-6909, 2023 | 78 | 2023 |
| Characterization of immune responses in fully vaccinated individuals after breakthrough infection with the SARS-CoV-2 delta variant AY Collier, CM Brown, KA McMahan, J Yu, J Liu, C Jacob-Dolan, ... Science translational medicine 14 (641), eabn6150, 2022 | 56 | 2022 |
| Durability of heterologous and homologous COVID-19 vaccine boosts CS Tan, YC Ai-ris, J Yu, J Liu, A Chandrashekar, K McMahan, ... JAMA network open 5 (8), e2226335-e2226335, 2022 | 55 | 2022 |
| Waning immunity against XBB. 1.5 following bivalent mRNA boosters N Lasrado, YC Ai-ris, J Miller, NP Hachmann, J Liu, M Sciacca, C Wu, ... BioRxiv, 2023 | 39 | 2023 |
| Comparable neutralization of the SARS-CoV-2 omicron BA. 1 and BA. 2 variants J Yu, YC Ai-ris, M Rowe, F Mardas, JD Ventura, H Wan, J Miller, O Powers, ... Medrxiv, 2022 | 35 | 2022 |
| Coronavirus disease 2019 messenger RNA vaccine immunogenicity in immunosuppressed individuals AY Collier, J Yu, K McMahan, J Liu, C Atyeo, JL Ansel, ZP Fricker, ... The Journal of infectious diseases 225 (7), 1124-1128, 2022 | 24 | 2022 |
| Characterization of immune responses in fully vaccinated individuals following breakthrough infection with the SARS-CoV-2 delta variant AY Collier, CM Brown, KA McMahan, J Yu, J Liu, C Jacob-Dolan, ... Science Translational Medicine, eabn6150, 2022 | 21 | 2022 |
| Immune responses in fully vaccinated individuals following breakthrough infection with the SARS-CoV-2 Delta variant in Provincetown, Massachusetts YC Ai-ris, CM Brown, K Mcmahan, J Yu, J Liu, C Jacob-Dolan, ... Medrxiv, 2021 | 18 | 2021 |
| Neutralization of SARS-CoV-2 omicron subvariant BA. 2.87. 1 N Lasrado, A Rössler, M Rowe, YC Ai-ris, DH Barouch Vaccine 42 (9), 2117-2121, 2024 | 12 | 2024 |
| Waning immunity and IgG4 responses following bivalent mRNA boosting N Lasrado, AY Collier, J Miller, NP Hachmann, J Liu, T Anand, ... Science Advances 10 (8), eadj9945, 2024 | 11 | 2024 |
| Homologous and heterologous vaccine boost strategies for humoral and cellular immunologic coverage of the SARS-CoV-2 omicron variant CS Tan, AY Collier, J Liu, J Yu, A Chandrashekar, K McMahan, H Wan, ... MedRxiv, 2021.12. 02.21267198, 2021 | 11 | 2021 |
| Publisher Correction: The NK cell receptor NKp46 recognizes ecto-calreticulin on ER-stressed cells S Sen Santara, DJ Lee, Â Crespo, JJ Hu, C Walker, X Ma, Y Zhang, ... Nature 618 (7964), E17-E17, 2023 | 8 | 2023 |
| Ad26. COV2. S or BNT162b2 boosting of BNT162b2 vaccinated individuals CS Tan, AY Collier, J Liu, J Yu, H Wan, K McMahan, X He, C Jacob-Dolan, ... medRxiv, 2021 | 6 | 2021 |
| Immunogenicity of the BA. 5 Bivalent mRNA Vaccine Boosters YC Ai-ris, J Miller, NP Hachmann, K McMahan, J Liu, EA Bondzie, ... BioRxiv, 2022 | 3 | 2022 |
| SARS-CoV-2 XBB. 1.5 mRNA booster vaccination elicits limited mucosal immunity N Lasrado, M Rowe, K McMahan, NP Hachmann, J Miller, C Jacob-Dolan, ... Science translational medicine 16 (770), eadp8920, 2024 | 2 | 2024 |
